Picture of ImmuPharma logo

IMM ImmuPharma Balance Sheet

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual balance sheet for ImmuPharma, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Cash and Short Term Investments5.861.650.6680.2080.187
Net Total Accounts Receivable
Net Total Receivables0.4821.131.340.6860.429
Prepaid Expenses
Total Other Current Assets
Total Current Assets7.433.352.341.340.885
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.4120.3530.390.1020.082
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets10.963.972.720.977
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities1.261.581.451.671.52
Total Long Term Debt
Total Debt
Total Liabilities1.261.581.451.671.52
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity9.654.412.521.06-0.543
Total Liabilities & Shareholders' Equity10.963.972.720.977
Total Common Shares Outstanding